€3.73
4.24% yesterday
Madrid, Apr 07, 05:30 pm CET
ISIN
ES0134950F36
Symbol
FAE
Sector
Industry

Faes Farma SAReg Stock price

€3.72
+0.26 7.37% 1M
+0.06 1.50% 6M
+0.24 6.75% YTD
+0.59 18.88% 1Y
-0.26 6.42% 3Y
-0.05 1.20% 5Y
+1.51 68.82% 10Y
Madrid, Closing price Mon, Apr 07 2025
-0.18 4.50%
ISIN
ES0134950F36
Symbol
FAE
Sector
Industry

Key metrics

Market capitalization €1.16b
Enterprise Value €1.09b
P/E (TTM) P/E ratio 10.38
EV/FCF (TTM) EV/FCF 13.38
EV/Sales (TTM) EV/Sales 2.21
P/S ratio (TTM) P/S ratio 2.34
P/B ratio (TTM) P/B ratio 1.59
Dividend yield 4.23%
Last dividend (FY24) €0.16
Revenue growth (TTM) Revenue growth 9.42%
Revenue (TTM) Revenue €493.65m
EBIT (operating result TTM) EBIT €108.53m
Free Cash Flow (TTM) Free Cash Flow €81.65m
EPS (TTM) EPS €0.36
P/E forward 11.73
P/S forward 2.23
EV/Sales forward 2.11
Show more

Is Faes Farma SAReg a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Faes Farma SAReg Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Faes Farma SAReg forecast:

2x Buy
40%
2x Hold
40%
1x Sell
20%

Analyst Opinions

5 Analysts have issued a Faes Farma SAReg forecast:

Buy
40%
Hold
40%
Sell
20%

Financial data from Faes Farma SAReg

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Dec '24
+/-
%
494 494
9% 9%
100%
- Direct Costs 292 292
8% 8%
59%
201 201
11% 11%
41%
- Selling and Administrative Expenses 73 73
10% 10%
15%
- Research and Development Expense - -
-
-
129 129
10% 10%
26%
- Depreciation and Amortization 20 20
5% 5%
4%
EBIT (Operating Income) EBIT 109 109
11% 11%
22%
Net Profit 111 111
21% 21%
23%

In millions EUR.

Don't miss a Thing! We will send you all news about Faes Farma SAReg directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Faes Farma SA operates as a pharmaceutical company. It engages in manufacturing and sale of chemical and pharmaceutical products, as well as the acquisition, purchase, sale, investment, holding, administration, management, negotiation and leasing of companies, of transferable and immovable securities, patents, trademarks and registrations and social participations. The company was founded in 1933 and is headquartered in Leioa, Spain.

Head office Spain
CEO Eduardo Cuadra
Founded 1933
Website faesfarma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today